Patrick Peterson

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski et al. · The Lancet · 2009 · 1.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Jean‐Yves Douillard, P. Koralewski et al. · Journal of Clinical Oncology · 2006 · 155 citations

Medicine, Oncology, Pharmacology +15

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Giorgio V. Scagliotti, C. Kortsik, G. Dark et al. · Clinical Cancer Research · 2005 · 137 citations · Full text

Medicine, Oncology, Pharmacology +16

P2-328: Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC)

Patrick Peterson, Keunchil Park, Frank V. Fossella et al. · Journal of Thoracic Oncology · 2007 · 110 citations · Full text

Medicine, Oncology, Pharmacology +13

Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study

Tudor–Eliade Ciuleanu, T. Brodowicz, Chandra P. Belani et al. · Journal of Clinical Oncology · 2008 · 98 citations

Medicine, Oncology, Pharmacology +15